BIOSPAIN Congress (26-28th September 2023)

Inhibitec’ s team had the privilege to participate in BIOSPAIN 2023, one of the main international biotechnology events in southern Europe, held in Barcelona. This was a dynamic conference marked by numerous meetings we had which offered the great opportunity to share our innovative therapy for Psoriatic Arthritis with potential investors and collaborators.

This platform allowed us to present our business project vision to some of the most relevant leaders in the healthcare and biotechnology sectors and proof our total commitment with the patients. The conversations were productive, and we are deeply grateful for the interest and support we received.

Share the Post:

Related Posts

Inhibitec Antibodies has been one of the startups selected in the ‘Programa Personal Tecnico I+D’ supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)...

Towards a new therapy in psoriasis and psoriatic arthritis Inhibitec Anticuerpos S.L. has been selected as a recipient of the grant CPP2022-009666, supporting the development...

Inhibitec is selected as finalist in the BIO-Europe Spring Startup Spotlight competition. This exciting competition offers entrepreneurs an affordable opportunity to engage with top-tier investors...

Scroll to Top